Experiences with
Alunbrig

2 public posts

FDA Approves Brigatinib for ALK-positive Metastatic NSCLC

In addition to the approval for Alunbrig (brigatinib), the FDA has approved the Vysis ALK Break Apart FISH Probe as a companion diagnostic for Alunbrig (brigatinib).

In addition to the approval for Alunbrig (brigatinib), the FDA has approved the Vysis ALK Break Apart FISH Probe as a companion diagnostic for Alunbrig (brigatinib).

Partnerin Lung Cancer Support

4 years ago

A new drug for ALK-positive lung cancer approved today

The drug is called brigatinib (brand name: Alunbrig) and is approved for treatment of patients whose tumor has the ALK mutation. Brigatinib is to be used after another drug targeting ALK stops working.

The drug is called brigatinib (brand name: Alunbrig) and is approved for treatment of patients whose tumor has the ALK mutation. Brigatinib is to be used after another drug targeting ALK stops working.

in Lung Cancer Support

8 years ago

Want to take advantage of all our features? Just log in!

or